Get started
Author

Babette Aicher

Observed names: Aicher, Babette, B Aicher, B. Aicher
OpenAlex ID: A5026087941
Cellular Redistribution of Protein Tyrosine Phosphatases LAR and PTPσ by Inducible Proteolytic Processing
1997 · Babette Aicher, Markus M. Lerch, et al. · The Journal of Cell Biology · 156
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
2017 · Daniela Massihnia, Amir Avan, et al. · Journal of Hematology & Oncology · 88
PDF
Mitogen‐activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment
2006 · Ralf Jauch, Min‐Kyu Cho, et al. · The EMBO Journal · 77
PDF
40th EASD Annual Meeting of the European Association for the Study of Diabetes
2004 · M. Veitenhansl, K. Stegner, et al. · Diabetologia · 70
Crystal Structures of the Mnk2 Kinase Domain Reveal an Inhibitory Conformation and a Zinc Binding Site
2005 · Ralf Jauch, Stefan Jäkel, et al. · Structure · 67
N-Benzoylated Phenoxazines and Phenothiazines: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2011 · Helge Prinz, Behfar Chamasmani, et al. · Journal of Medicinal Chemistry · 65
GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax
2009 · Stefanie Fister, Andreas R. Günthert, et al. · Cancer Research · 62
The synthesis of Rantes, G‐CSF, IL‐4, IL‐5, IL‐6, IL‐12 and IL‐13 in human whole‐blood cultures is modulated by an extract from Eleutherococcus senticosus L. roots
2001 · M. W. Schmolz, F. Sacher, et al. · Phytotherapy Research · 48
Current View on the Mechanism of Action of Perifosine in Cancer
2014 · Joachim Fensterle, Babette Aicher, et al. · Anti-Cancer Agents in Medicinal Chemistry · 35
A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis
2017 · Nina Hanke, Michael Teifel, et al. · Cancer Chemotherapy and Pharmacology · 23
Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes
2007 · Karem Shanab, Nipawan Pongprom, et al. · Bioorganic & Medicinal Chemistry Letters · 22
Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives
2010 · Karem Shanab, Eva Schirmer, et al. · Bioorganic & Medicinal Chemistry Letters · 13
Discovery of 7‐Aryl‐Substituted (1,5‐Naphthyridin‐4‐yl)ureas as Aurora Kinase Inhibitors
2013 · Julien Defaux, Maud Antoine, et al. · ChemMedChem · 12
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell lines
2010 · Martin Schmidt-Hieber, Robert Dabrowski, et al. · Investigational New Drugs · 10
New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center
2016 · Mathieu Maingot, Anne-Laure Blayo, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells
2014 · Julien Defaux, Maud Antoine, et al. · Bioorganic & Medicinal Chemistry Letters · 9
New trisubstituted 1,2,4-triazoles as ghrelin receptor antagonists
2014 · Anne-Laure Blayo, Mathieu Maingot, et al. · Bioorganic & Medicinal Chemistry Letters · 7
Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II
2011 · Karem Shanab, Eva Schirmer, et al. · Bioorganic & Medicinal Chemistry Letters · 7
Synthesis and antiproliferative activity of new cytotoxic tri- and tetraazabenzo[3,2-a]fluorene-5,6-dione derivatives
2013 · Theerachart Leepasert, Manochehr Shahabi, et al. · Bioorganic & Medicinal Chemistry Letters · 6
Abstract C214: Disorazol Z: A highly cytotoxic natural compound with antitumor properties.
2011 · Babette Aicher, Kerstin Hirschfelder, et al. · Molecular Cancer Therapeutics · 6
Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors
2015 · Maud Antoine, Tilmann Schuster, et al. · MedChemComm · 5
Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh]isoquinolinone derivatives
2013 · Manochehr Shahabi, Eva Schirmer, et al. · Bioorganic & Medicinal Chemistry Letters · 4
In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors
2011 · Martin Schmidt-Hieber, Robert Dabrowski, et al. · Investigational New Drugs · 4
330 Highly Potent Cytotoxic Conjugates of Disorazol Z Linked to a LHRH Receptor Targeting Peptide Interfere with Cell Cycle Progression in Human Cancer Cell Lines and Suppress Tumor Growth in a LHRH Receptor Positive Ovarian Cancer Xenograft Model
2012 · B. Aicher, T. Schuster, et al. · European Journal of Cancer · 3
MP-02.03: The LHRH Receptor Antagonist Cetrorelix Exhibits Agonistic Activity Against the Orphan GPCR Mrgx2: A Novel Mode of Action?
2009 · B. Aicher, P. Schmidt, et al. · Urology · 2
Works count: 44
Citation count: 814
H-index: 12
I10-index: 14
Year
Topic
Type